Specifically, Aβ deregulates neurotransmitter release from the presynaptic site from studies both in vitro with oligomer Aβ-treated primary neuronal cultures and in vivo AD mouse models overexpressing amyloid precursor protein (APP)/Aβ13–15. This evidence concerns the gene APP and Alzheimer disease.